|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||82.66 - 83.70|
|52 Week Range||52.17 - 85.00|
|PE Ratio (TTM)||85.67|
|Earnings Date||Aug 22, 2018 - Aug 27, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||82.15|
Thanks to a hefty amount of growth, high demand, fat margins and plenty of cash flow generation, both tech and healthcare stocks have surged since the end of the recession. Dubbed MedTech stocks, these firms feature plenty of innovative muscle. Which MedTech stocks have the goods to power your portfolio?
Veeva Systems (VEEV) today announced that Samsung BioLogics selected Veeva Vault QualityDocs to modernize quality document management. Vault QualityDocs enables Samsung BioLogics to provide transparency into content status and processes for internal and external users, partners, and suppliers worldwide. The company can also better scale its document control processes and ensure global alignment across the business.
Short interest is low for VEEV with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $546 million over the last one-month into ETFs that hold VEEV are among the lowest of the last year and appear to be slowing.
Veeva Systems (VEEV) today announced that Idorsia Pharmaceuticals Ltd established an integrated development landscape with Veeva Development Cloud. With unified applications for clinical, regulatory, and quality on a single cloud platform, Idorsia now has the technology foundation to accelerate product innovation and support its global growth plans. “With a strong pipeline of innovative new therapies, we needed cutting-edge cloud technology that could scale as we grow,” said Joseph Bejjani, CIO at Idorsia.
Like a winning Major League Baseball club, Federated Kaufmann Small Cap Fund's success owes much to team work.
Over the past year, there has been significant industrywide momentum toward streamlining clinical systems and processes, according to one of the largest annual life sciences surveys of clinical operations professionals from Veeva Systems .
Over the past year, there has been significant industrywide momentum toward streamlining clinical systems and processes, according to one of the largest annual life sciences surveys of clinical operations professionals from Veeva Systems (VEEV). The latest findings of the Veeva 2018 Unified Clinical Operations Survey reveal that nearly all (99%) clinical leaders surveyed cite the need to unify their clinical environment. Most (87%) report their organizations are taking action with initiatives planned or underway to unify their clinical operations for improved trial performance.
Veeva Systems (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Veeva Systems Inc (NYSE:VEEV) saw a decent share price growth in the teens level on the NYSE over the last few months. As a large-cap stock with high coverage byRead More...
Veeva Systems (VEEV) today announced that leading pharmaceutical companies and CROs are now using Veeva Vault EDC to improve data management in their clinical trials. In just over a year since the product’s availability, 12 early adopters have initiated studies with Vault EDC, including a top 20 global pharmaceutical company. “The ability to effectively manage clinical data is essential as trials become more complex,” said Alison Liddy, SVP clinical risk and data management at ICON, who is running a trial on behalf of a customer leveraging Veeva Vault EDC.
At the upcoming DIA 2018 Annual Meeting, Tufts Center for the Study of Drug Development (CSDD) will preview its study findings on the root causes for delays and inefficiencies impacting trial timelines. As a follow-up to the 2017 eClinical Landscape Study, sponsored by Veeva Systems (VEEV), Tufts CSDD spoke with more than 40 data management executives about the top challenges and opportunities in clinical data management. Findings indicate there is a significant opportunity to transform data management practices for greater agility and to accelerate adoption of risk-based approaches.
The media went full throttle in covering the exit of centuries-old GE from the Dow Jones industrial average, but the truly dynamic action for investors continued to center on fast-growing companies on the Nasdaq, including PayPal and Alphabet.
Stock Research Monitor: PINC, RCM, and VEEV LONDON, UK / ACCESSWIRE / June 15, 2018 / If you want a free Stock Review on BR sign up now at www.wallstequities.com/registration . On Thursday, benchmark US ...
Stock futures were little changed. Alibaba, ServiceNow, Red Hat, Veeva Systems are all in buy zones and on the Rising Profit Estimates list.
With little capital expenditure needed, such companies create a virtuous cycle in which they can grow, generate cash and reinvest back into their businesses," wrote Rosenberg. Rosenberg is upbeat on Aspen Technology, which provides automation solutions for global process corporations in industries such as engineering, construction, petroleum and chemicals.
Veeva Systems Inc. a leading industry cloud provider for life sciences, today announced that Tim Cabral, CFO, will present at the Bank of America Merrill Lynch 2018 Global Technology Conference on Wednesday, June 6, 2018, at 2:20 p.m.
Veeva Systems (VEEV) today announced Veeva Vault Training, a new cloud application to simplify role-based training across life sciences organizations and help quality teams remain audit-ready and compliant. Together with Veeva Vault QMS and Veeva Vault QualityDocs, Veeva will deliver a unified suite of quality applications on a single cloud platform that brings together training with quality processes and document control for seamless, end-to-end quality management.